HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Hu Selected Research

isobutyric acid

8/2022L-norvaline affects the proliferation of breast cancer cells based on the microbiome and metabolome analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Hu Research Topics

Disease

151Neoplasms (Cancer)
11/2022 - 02/2006
48Multiple Myeloma
01/2022 - 02/2005
37COVID-19
10/2022 - 01/2020
28Inflammation (Inflammations)
10/2022 - 07/2006
26Thrombosis (Thrombus)
05/2022 - 09/2004
18Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 05/2012
15Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 01/2011
14Hemorrhage
01/2022 - 01/2002
13Infections
06/2022 - 12/2008
12Hepatocellular Carcinoma (Hepatoma)
08/2022 - 09/2009
12Neoplasm Metastasis (Metastasis)
06/2022 - 12/2009
12Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 02/2007
11Carcinogenesis
01/2022 - 07/2006
10Measles
01/2021 - 12/2011
9Alzheimer Disease (Alzheimer's Disease)
03/2021 - 01/2015
9Atherosclerosis
01/2021 - 10/2008
9Leukemia
01/2021 - 02/2003
8Glioma (Gliomas)
09/2022 - 12/2013
8Thrombocytopenia (Thrombopenia)
01/2022 - 01/2012
8Disease Progression
01/2021 - 05/2010
8Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2020 - 01/2004
8Venous Thrombosis (Deep-Vein Thrombosis)
01/2018 - 01/2009
7Poliomyelitis (Polio)
12/2022 - 05/2014
7Cardiovascular Diseases (Cardiovascular Disease)
05/2022 - 09/2004
7Insulin Resistance
03/2022 - 10/2015
7Pituitary Neoplasms (Pituitary Adenoma)
07/2021 - 11/2017
7Disseminated Intravascular Coagulation
01/2021 - 01/2017
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 04/2014
6Breast Neoplasms (Breast Cancer)
08/2022 - 12/2018
6Cognitive Dysfunction
01/2022 - 01/2015
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 07/2012
6Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 06/2007
6Carcinoma (Carcinomatosis)
12/2019 - 01/2006
5Diphtheria
12/2022 - 05/2014
5Tetanus
12/2022 - 05/2014
5Carotid Artery Diseases
10/2022 - 03/2014
5Hypoxia (Hypoxemia)
12/2021 - 10/2015
5Stomach Neoplasms (Stomach Cancer)
07/2021 - 01/2019
5Hyperglycemia
01/2021 - 04/2015
5Lymphoma (Lymphomas)
01/2021 - 11/2018
5Coronary Disease (Coronary Heart Disease)
11/2020 - 03/2003
5Infarction (Infarctions)
01/2020 - 05/2013
5Ischemia
10/2017 - 06/2005
4Whooping Cough (Pertussis)
12/2022 - 05/2014
4Obesity
07/2022 - 01/2018
4Osteoporosis
04/2022 - 02/2016
4Sepsis (Septicemia)
02/2022 - 02/2013

Drug/Important Bio-Agent (IBA)

41Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2005
34Biomarkers (Surrogate Marker)IBA
08/2022 - 08/2008
25Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2017 - 02/2005
23MicroRNAs (MicroRNA)IBA
03/2022 - 05/2012
17VaccinesIBA
12/2022 - 12/2011
17Biological ProductsIBA
06/2022 - 12/2005
17Thromboplastin (Tissue Factor)IBA
01/2020 - 03/2003
15Inosine Triphosphate (ITP)IBA
01/2022 - 01/2011
14LipidsIBA
10/2022 - 01/2005
14CytokinesIBA
10/2022 - 01/2005
14Interleukin-6 (Interleukin 6)IBA
08/2022 - 01/2005
14Glucose (Dextrose)FDA LinkGeneric
03/2022 - 03/2014
14RNA (Ribonucleic Acid)IBA
01/2022 - 02/2015
14Pharmaceutical PreparationsIBA
10/2021 - 12/2013
13Long Noncoding RNAIBA
10/2022 - 01/2018
11Therapeutic UsesIBA
05/2022 - 01/2015
11Chimeric Antigen ReceptorsIBA
01/2022 - 07/2019
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 02/2005
11fibrin fragment D (D-dimer)IBA
01/2021 - 01/2017
10Messenger RNA (mRNA)IBA
01/2022 - 01/2002
10AntigensIBA
01/2022 - 02/2003
10Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 12/2013
9Dacarbazine (DIC)FDA LinkGeneric
01/2021 - 01/2015
9Small Interfering RNA (siRNA)IBA
02/2019 - 09/2007
8AntibodiesIBA
01/2022 - 10/2007
8Imatinib Mesylate (Gleevec)FDA Link
01/2021 - 01/2009
7Rituximab (Mabthera)FDA Link
01/2021 - 04/2014
6InflammasomesIBA
08/2022 - 12/2010
6Interleukin-17 (Interleukin 17)IBA
10/2021 - 08/2011
6ORALIT (ORS)IBA
01/2021 - 01/2018
6EnzymesIBA
10/2020 - 02/2006
5AntioxidantsIBA
05/2022 - 04/2015
5Immunoglobulins (Immunoglobulin)IBA
05/2022 - 05/2013
5Insulin (Novolin)FDA Link
03/2022 - 11/2018
5Polysaccharides (Glycans)IBA
01/2022 - 04/2015
5Bortezomib (Velcade)FDA Link
01/2022 - 08/2012
5FibrinIBA
04/2021 - 01/2016
5Apolipoproteins E (ApoE)IBA
01/2021 - 01/2018
5Alanine Transaminase (SGPT)IBA
01/2021 - 10/2015
5Fibrinogen (Factor I)FDA Link
01/2021 - 04/2002
5Oxygen (Dioxygen)IBA
01/2020 - 01/2016
5Fibronectins (Fibronectin)IBA
01/2020 - 04/2014
5ResveratrolIBA
12/2019 - 02/2006
5Factor VII (Proconvertin)IBA
04/2016 - 06/2005
4Combined VaccinesIBA
12/2022 - 05/2014
4oxidized low density lipoproteinIBA
10/2022 - 01/2016
4Indicators and Reagents (Reagents)IBA
10/2022 - 04/2008
4Blood Glucose (Blood Sugar)IBA
01/2022 - 07/2018

Therapy/Procedure

73Therapeutics
05/2022 - 01/2002
22Drug Therapy (Chemotherapy)
04/2022 - 02/2008
13Hematopoietic Stem Cell Transplantation
01/2022 - 08/2015
12Immunotherapy
01/2022 - 09/2013
7Radiotherapy
01/2022 - 01/2012